✦ LIBER ✦

Pharmacokinetics of BOF-4272, a Xanthine Oxidase Inhibitor, after Single Intravenous or Oral Administration to Male Mice and Rats

✍ Scribed by SHINSAKU NAITO; MASUHIRO NISHIMURA; HIROYUKI NOGAWA

Book ID: 111769759
Publisher: Pharmaceutical Press
Year: 1999
Tongue: English
Weight: 126 KB
Volume: 51
Category: Article
ISSN: 2042-7158
DOI: 10.1211/0022357991772358

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Plasma pharmacokinetics of butyrate afte

Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats

✍ Merrill J. Egorin; Zhi-Min Yuan; Dorothy L. Sentz; Karen Plaisance; Julie L. Eis 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 159 KB

Pharmacokinetics of a novel HIV-1 protea

Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice

✍ Jean-Christophe Leroux; Eric Doelker; Robert Gurny; Robert Cozens; Johannes L. R 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 562 KB

Pharmacokinetics of a New Proton-pump In

Pharmacokinetics of a New Proton-pump Inhibitor, YJA-20379-8, after Intravenous and Oral Administration to Rats with Streptozotocin-induced Diabetes Mellitus

✍ Su Y. Chung; Kye S. Han; Sang K. Shon; Man S. Chang; Myung G. Lee 📂 Article 📅 1999 🏛 Pharmaceutical Press 🌐 English ⚖ 94 KB

Pharmacokinetics of a new proton pump in

Pharmacokinetics of a new proton pump inhibitor, YJA-20379-8, after intravenous and oral administration to spontaneously hypertensive rats and DOCA-salt-induced hypertensive rats

✍ Ho J. Kim; Kye S. Han; Yoon G. Kim; Young-K. Chung; Man S. Chang; Myung G. Lee 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract The purpose of this study was to investigate the causes for the differences observed in the pharmacokinetics of YJA‐20379‐8 in 16‐week‐old spontaneously hypertensive rats (SHRs). To see if the hereditary characteristics of SHRs was the cause, 20 mg/kg of the drug was intravenously infus

Dose-dependent pharmacokinetics of a new

Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect

✍ Eun J. Kim; Sun-O. Kim; Dong H. Lee; Hong Lim; Myung G. Lee 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views

Dose-independent pharmacokinetics of a n

Dose-independent pharmacokinetics of a new reversible proton pump inhibitor, KR-60436, after intravenous and oral administration to rats: Gastrointestinal first-pass effect

✍ Su Yeon Yu; Soo Kyung Bae; Eun Jung Kim; Yoon Gyoon Kim; Sun-Ok Kim; Dong Ha Lee 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Dose-independent pharmacokinetic parameters of KR-60436, a new proton pump inhibitor, were evaluated after intravenous (i.v.; 5, 10, and 20 mg/kg) and oral (20, 50, and 100 mg/kg) administration to rats. The hepatic, gastric, and intestinal first-pass effects were also measured after iv, intraportal